IVF Health Risk 503,000 Hit in Google in 0.2 seconds

Similar documents
Overview. In Vitro Fertilization: a Success Story

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Number of oocytes and live births in IVF

Embryo Selection after IVF

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Recent Developments in Infertility Treatment

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Articles Follow-up of children born after assisted reproductive technologies

Dr Manuela Toledo - Procedures in ART -

OOCYTE DONATION: AN OVERVIEW

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Reproductive Techniques

Infertility treatment

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

Health of children born after ovulation induction

Disclosure. Lyubov Mykhaylshyn IVF department Alternativa clinic Lviv, Ukraine

Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers

Risk factors for monozygotic twinning in IVF: a multicenter, cohort study

Dr Devashana Gupta. Dr Karen Buckingham. Obstetrician and Gynaecologist Repromed. Repromed Auckland

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Supplementary Online Content

Disclosures. Win Fertility UpToDate

2018 INFERTILITY TRENDS NATIONAL SURVEY

International Federation of Fertility Societies. Global Standards of Infertility Care

PGS Embryo Screening

Hold On To Your Dreams

Understanding IVF Processes in Surrogacy

Report to the Director-General of Health on the Risks and Benefits Associated with Assisted Reproductive Technologies

How to advise the couple planning to conceive: Modifiable factors that may (or may not) impact fertility

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Freeze-All Policy: Is It Right for Everyone?

How to make the best use of the natural cycle for frozen-thawed embryo transfer?

European IVF Monitoring (EIM) Year: 2013

Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

College of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE

Reproductive Techniques

European IVF Monitoring (EIM) Year: 2012

Chromosomal Aneuploidy

Children born after assisted fertilization have an increased rate of major congenital anomalies

Clinical Policy Committee

Original Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Sample size a Main finding b Main limitations

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Myths About Success Rates Do they truly reflect quality of care

The first live birth after the transfer

A Tale of Three Hormones: hcg, Progesterone and AMH

Genetics Review and Reproductive Options in Kennedy Disease

Recording and measuring the outcome of an ART cycle

r e p r o d u c t i v e b i o l o g y x x x ( ) x x x x x x Available online at ScienceDirect

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

Bumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.

Reproductive Medicine Module 4a: Subfertility and Assisted Conception 4a: General Subfertility

Births following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI

Progesterone and clinical outcomes

PhD THESIS SARA SOFIA MALCHAU LAUESGAARD ACADEMIC SUPERVISORS

Rejuvenation of Gamete Cells; Past, Present and Future

Clinical Policy Committee

Which one has a better obstetric and perinatal outcome in singleton pregnancy, IVF/ICSI or FET?: a systematic review and meta-analysis

WHAT IS A PATIENT CARE ADVOCATE?

Dr Veenu Gupta MD MRCPsych Consultant, Child Psychiatrist Stockton on Tees, UK

The old IVF patient: An evidence based approach. Stratis Kolibianakis MD MSc PhD

Does PCOS Compromise the oocyte and embryo quality or the endometrium?

Assisted Reproductive Technologies

Fertility What do GP s need to know? Richard Fisher Fertility Associates

President : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman ICOG. Founder Trustee Women s Empowerment Foundation

Infertility. Thomas Lloyd and Samera Dean

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

POST - DOCTORAL FELLOWSHIP PROGRAMME IN REPRODUCTIVE MEDICINE. Anatomy : Male and Female genital tract

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018

Reproductive Technology, Genetic Testing, and Gene Therapy

Abstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online; on web 24 August 2009

Review of unexplained infertility and obstetric outcome: a 10 year review

Abstract. Introduction. Materials and methods. Patients and methods

but it still needs a bit of work

Should every pregnant woman be screened for thyroid disease?

Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience,

Problem Challenge Need. Solution Innovation Invention

Does a woman s educational attainment influence in vitro fertilization outcomes?

The development of assisted reproductive

Assisted Reproductive Technology National Summary Report Belgium 2015

Fertility Policy. December Introduction

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

FRESH VERSUS FROZEN EMBRYO TRANSFER OVERVIEW

Neil Goodman, MD, FACE

INDICATIONS OF IVF/ICSI

Transcription:

Assisted Reproductive Technologies and Perinatal Morbidity: Interrogating the Association Kurt Barnhart, M.D., MSCE. William Shippen Jr Professor of Obstetrics and Gynecology and Epidemiology Perelman School of Medicine University of Pennsylvania No disclosures Objectives: 1) To understand the risks of children born with assisted conception 2) To assesses the quality of evidence to support risk 3) To be familiar with new studies assessing behavior and development of children born after ART First successful IVF in the UK in 1978 200,000 cycles in US in 2008 alone 61,00 live birth deliveries Dramatic increase in success rates Demand for IVF continues to rise Background www.cdc.gov/art/2005

IVF Health Risk 503,000 Hit in Google in 0.2 seconds Do IVF kids face more health risks? MSNBC July 2003 IVF health risks pinpointed Bioed on line 2004 More Health Risks Found in IVF Babies - Scientist Suggests IVF Children Should be Monitored into Adulthood LifeSiteNews.com 2007 Picture Emerging on Genetic Risks of IVF New York Times 2009 Is it fair to lump all infertility treatments together? Does the public know the difference? Do other medical disciplines know the difference? Do regulators know the difference? Diagnosis in Patients Undergoing IVF in the United States 2002 SART/CDC Report (Published December 2005)

What is ART Assisted Reproductive Technology - Intracervical Insemination - Intrauterine Insemination - Ovulation induction - Superovulation IVF IVF-ET Ovarian stimulation Egg retrieval Laboratory Environment Culture media Atmosphere Technique(s) Embryo transfer Luteal support Environment at implantation Micromanipulation of the Embryo ICSI Assisted Hatching Blastomere biopsy Preimplantation diagnosis Gamete freezing

Oocyte retrieval

What are the Risks? Perinatal outcomes Maternal outcomes Congenital abnormities Genetic abnormality Developmental delay Autism What is relative risk, absolute risk What should we do about it?

Preterm Delivery Jackson et al., Perinatal Outcomes in Singletons Following In Vitro Fertilization: A Meta Analysis Obstet Gynecol 103:551-563, 563, 2004 Low Birth Weight Jackson et al Obstet Gynecol 103:551-563, 563, 2004 Small for Gestational Age Jackson et al Obstet Gynecol 103:551-563, 563, 2004

Perinatal Mortality Jackson et al Obstet Gynecol 103:551-563, 563, 2004 Secondary Outcomes Jackson et al Obstet Gynecol 103:551-563, 563, 2004 FASTER Trial ART (OI 1200, IVF 550) vs unassisted conception (36,000) Preterm labor 5.2% v 6.9% Low birth weight 5.1% v 5.9% Growth restriction 1.1% v 0.9% No association aneuploidy or other fetal anomalies Conflict with other studies? Prospective nature removed confounding? IVF group small in comparison to prior studies? Shevell et al. for the FASTER Research Consortium Obstet Gynecol 106:1039, 2005

Shevell et al. for the FASTER Research Consortium Obstet Gynecol 106:1039, 2005 Shevell et al. for the FASTER Research Consortium Obstet Gynecol 106:1039, 2005 Preterm Delivery and IVF Singletons Risk of delivery <37 weeks is 70-100% increased with IVF Vast majority (90%) are uncomplicated Baseline e rate in unassisted sted conceptions has been low (5-8%) Limited data to regarding clinical implications of PTD or SGA.

Assisted Reproductive Technologies and Perinatal Morbidity Issues of importance Etiology Is the association true (Bias? Confounding?) If true, is it due to the underlying condition? If true, is it due to procedures/methods of ART? How can risk be reduced? Goal is identify a modifiable practice, and change it, not eliminate ART Is there perinatal morbidity associated with infertility? Prolonged Time to Pregnancy is Associated with a Greater Risk of Adverse Outcomes Kuopio University Hospital (Finland) between 1989 and 2007 (n=17,114) Raatikainen. Time to pregnancy and adverse outcomes. Fertil Steril 2009.

Prolonged time to pregnancy is associated with a greater risk of adverse outcomes We conclude that subfertility, irrespective of treatment, is clearly associated with the risk of an adverse outcome during pregnancy. The common etiologic mechanisms associated with both subfertility and pregnancy complications need further investigation. Raatikainen. Time to pregnancy and adverse outcomes. Fertil Steril 2009. Adverse Obstetric and Perinatal Outcomes in Subfertile Women Conceiving Without ART ART records linked to national birth registry in Australia 1999-2004 (Jacques M. Adverse obstetric and perinatal outcomes in subfertile women conceiving without ART.) Health of Children Born After Ovulation Induction Reija Klemetti, Ph.D.,a Tiina Sevon, M.Soc.Sc.,a Mika Gissler, Dr.Phil.,b and Elina Hemminki, (Finnish national registry) The OI children had poorer perinatal health and more episodes of long hospitalization than the control children. Either OI treatment or the reasons for the treatment increase the risk of health problems in early childhood. (Klemetti. Health of OI children. Fertil Steril. 2009)

What about IVF? Can one isolate the aspects of IVF that may be associated with morbidity IVF is a complex set of procedures/technigues: Usual suspects: ICSI Extended culture Poor embryo quality? Factor of IVF Associated with Perinatal Morbidity: Case/Control 159 cases 276 controls Chung and Barnhart et al, Fertil Steril, 2006 Variables p- value Type of medication 0.60 Recombinant Adjusted OR (95% CI) Reference group Urinary 0.65 (0.13-3.27) 3.27) ICSI 0.25 1.40 (0.79-2.50) AH 0.39 1.32 (0.70-2.48) Embryo grade (best) 0.14 0.81 (0.60-1.07) Embryo stage (best) 0.87 0.98 (0.79-1.22) Factor of IVF Associated with Perinatal Morbidity: Case/Control Variables p-value Adjusted OR (95% CI) Multiple gestation <0.0001* 11.94 (7.29-19.54) Endometrial thickness 0.028* 0.89 (0.80-0.99) 0.99) on day of hcg < 10 mm 0.026* 2.04 (1.09-3.83) 10-1212 mm 0.568 1.19 (0.65-2.17) >12 mm Reference group Ovarian hyperstimulation 0.036* 3.14 (1.08-9.14) syndrome Chung and Barnhart et al, Fertil Steril, 2006

Implantation? To determine the association of adverse perinatal outcomes in patients undergoing frozen embryo transfer as compared to fresh embryo transfer in a cohort of patients at Penn Fertility Care. Adverse Outcomes Associated with In-Vitro Fertilization: The Impact of the Intrauterine Environment in Fresh versus Frozen Embryo Transfer. Suleena Kansal Kalra, MD, MSCE; Sarah J. Ratcliffe, PhD, Lauren Weissmann, MD; Clarisa R. Gracia, MD, MSCE, Christos Coutifaris, MD, PhD, Kurt T. Barnhart, MD, MSCE Fresh vs Frozen/Thawed as a Model for Endocrine Milieu at Transfer Analysis of adverse outcomes in fresh versus frozen embryo transfers and twin gestation Note: AOR ¼ adjusted odds ratio; CI ¼ confidence interval; ET ¼ embryo transfer; IUGR ¼ intrauterine growth restriction; LBW ¼ low birthweight; OR ¼ odds ratio; xxx ¼ insufficient numbers for statistical analysis. a Any one of clinical pregnancy loss, biochemical loss, or ectopic pregnancy. b Second-trimester pregnancy loss. c Preterm delivery, IUGR, and/or low birth weight. d Any one of clinical pregnancy loss, biochemical loss, ectopic pregnancy, second-trimester loss, preterm delivery, IUGR, and low birth weight. e Generalized estimating equation adjustment for correlations. f Adjusted for fresh embryo transfer, twin gestation (although first-trimester loss was not adjusted for twin gestation, because plurality was not known), maternal age at transfer, ovarian hyperstimulation syndrome in source cycle, and parity. g Adjusted for fresh embryo transfer, maternal age at transfer, ovarian hyperstimulation syndrome in source cycle, and parity. Kansal Kalra. Fresh versus frozen embryo transfer. Fertil Steril 2011. Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer Suleena Kansal Kalra, M.D., M.S.C.E.,a Sarah J. Ratcliffe, Ph.D.,b Lauren Milman, M.D.,aClarisa R. Gracia, M.D., M.S.C.E.,a Christos Coutifaris, M.D., Ph.D.,a and Kurt T. Barnhart, M.D., M.S.C.E.a,bFertility and Sterility 2011: 95, Ovarian Stimulation and Low Birth Weight in Newborns Conceived Through In Vitro Fertilization OBGYN, OCTOBER 2011 Suleena Kalra, MD, MSCE, Sarah J. Ratcliffe, PhD, Christos Coutifaris, MD, PhD, Thomas Molinaro, MD, MSCE, Kurt T. Barnhart, MD, MSCE SART database 2004 2006 68,194 pregnancies (Fresh ET: n=44,721; FET: n=23,473) Three analyses: 1)All good prognosis patients 2)Those with both a fresh and frozen transfer, 3) Those with egg donation

Preterm Delivery in Singleton Live Births Following Fresh vs. Frozen Embryo Transfer Preterm Delivery N=32,065 Fresh ET Frozen ET OR (95% CI) AOR (95% CI)* Fullterm 81.1% (17,099/21,083) 81.5% (8,947/10,982) Reference Reference Preterm Delivery 16.0% 15.8% 1.01 (0.95-1.08) 1.06 (0.98-1.14) (32 37 wks) (3,377/21,083) (1,737/10,982) p=0.65 P=0.16 Very Preterm (<32 wks) 2.9% (607/21,083) 2.7% (298/10,982) 1.05 (0.91-1.21) p=0.46 ** *Adjusted for reporting year, patient age, parity, infertility diagnosis, number of embryos transferred, number of prior ART cycles, prior miscarriage, reduction in fetal heart, multiple pregnancy, and implantation rate ** For adjusted analysis, preterm and very preterm delivery combined Kalra et al: OBGYN 2011 Low Birthweight in Singleton Live Births Following Fresh vs. Frozen Embryo Transfer Low Birthweight N=31,822 Fresh ET Frozen ET OR (95% CI) AOR (95% CI)* Overall LBW 10.0% 7.2% 1.44 (1.33-1.57) 1.35 (1.20-1.51) (<2500 g) (2,094/20,916) (782/10,906) p<0.001 p<0.001 Term LBW 2.5% 1.2% 2.10 (1.69-2.60) 1.73 (1.31-2.29) (> 37 weeks, <2500 g) (422/16,962)) (107/8,877) p<0.001 p=0.001 Preterm LBW 34.1% 23.8% 1.66 (1.45-1.89) 1.49 (1.24-1.78) (<37 weeks, <2500 g) (1,138/3,341) (407/1,714) p<0.001 p<0.001 *Adjusted for reporting year, patient age, parity, infertility diagnosis, number of embryos transferred, number of prior ART cycles, prior miscarriage, reduction in fetal heart, multiple pregnancy, and implantation rate ** For adjusted analysis, preterm and very preterm delivery combined Kalra et al: OBGYN 2011 * Preterm Delivery in Twin Live Births Following Fresh vs. Frozen Embryo Transfer Preterm Delivery (n=14,598) Fresh ET Frozen ET OR (95% CI) AOR (95% CI)* Fullterm 23.5% (2,689/11,454) 23.7% (745/3,144) Reference Reference Preterm Delivery 62.8% 63.3% 1.00 (0.91-1.10) 1.03 (0.91-1.16) (32-37 wks) (7,196/11,454) (1,989/3,144) p=0.96 p=0.64 Very Preterm (<32 wks) 13.7% (1,569/11,454) 13.0% (410/3,144) 1.06 (0.93-1.21) p=0.40 ** *Adjusted for reporting year, patient age, parity, infertility diagnosis, number of embryos transferred, number of prior ART cycles, prior miscarriage, reduction in fetal heart, multiple pregnancy, and implantation rate ** For adjusted analysis, preterm and very preterm delivery combined Kalra et al: OBGYN 2011

Low Birthweight in Twin Live Births Following Fresh vs. Frozen Embryo Transfer Low Birthweight N=14,450 Fresh ET Frozen ET OR (95% CI) AOR (95% CI)* Overall LBW (<2500 g) 69.9% (7,924/11,339) 61.5% (1,912/3,111) 1.46 (1.34-1.58) p<0.001 1.36 (1.22-1.52) p<0.001 Term LBW (> 37 wks, <2500 g) 32.7% (873/2,670) 26.1% (192/737) 1.38 (1.15-1.66) p = 0.001 1.73 (1.31-2.29) p=0.001 Preterm LBW (<37 wks, <2500 g) 77.6% (5,536/7,132) 67.2% (1,324/1,971) 1.69 (1.52-1.89) p<0.001 1.59 (1.38-1.84) p<0.001 *Adjusted for reporting year, patient age, parity, infertility diagnosis, number of embryos transferred, number of prior ART cycles, prior miscarriage, reduction in fetal heart, multiple pregnancy, and implantation rate ** For adjusted analysis, preterm and very preterm delivery combined Kalra et al: OBGYN 2011 Preterm Delivery and Low Birthweight in Singletons Following Fresh vs. Frozen Embryo Transfer in Same Patient at Different Times: Paired Cycle Analysis N= 1,356 Fresh ET n= 680 Frozen ET n=676 OR (95% CI) AOR* (95% CI) Fullterm 81.1% (550/678) 82.2% (555/675) Reference Reference Preterm Delivery (32-37 wks) 14.9% (101/678) 15.9% (107/675) 1.03 (0.73-1.46) p=0.49 1.86 (0.73-4.71) p=0.19 Very Preterm 4.0% 1.9% 2.44 (1.14-5.20) (<32 wks) (27/678) (13/675) p=0.02 002 ** Overall LBW (<2500 g) 11.5% (78/680) 5.6% (38/676) 2.52 (1.59-4.00) p<0.001 4.66 (1.18-18.38) p = 0.03 Term LBW (> 37 wks, <2500 g) 2.4% (13/550) 1.1% (6/555) 3.33 (0.92-12.11) p=0.07 Not performed Preterm LBW (<37 wks, <2500 g) 50.8% (65/128) 26.7% (32/120) 1.86 (0.74-4.65) p=0.19 Not performed *Adjusted for reporting year, patient age, parity, infertility diagnosis, number of embryos transferred, number of prior ART cycles, prior miscarriage, reduction in fetal heart, multiple pregnancy, and implantation rate ** For adjusted analysis, preterm and very preterm delivery combined Kalra et al: OBGYN 2011 Preterm Delivery and Low Birthweight in Singleton Live Births Following Fresh vs. Frozen Embryo Transfer in Donor Recipients Singletons N=8,768 Fullterm Fresh ET Frozen ET OR (95% CI) AOR (95% CI)* 76.6% 75.7% Reference Reference (4,328/5,648) (2,361/3,120) Preterm Delivery (32-37 wks) 19.3% (1,091/5,648) 20.7% (646/3,120) 0.93 (0.83-1.03) p=0.16 0.96 (0.84-1.09) p=0.50 Very Preterm 4.1% 3.6% 1.08 (0.86-1.36) (<32 wks) (229/5,648) (113/3,120) p=0.48 ** Overall LBW 11.5% (644/5,595) 11.3% (346/3,072) 1.03 (0.90-1.18) p=0.65 0.99 (0-82-1.18) p=0.87 Term LBW 2.2% (93/4,286) 1.7% (39/2,325) 1.30 (0.89-1.89) p=0.17 1.41 (0.82-2.42) p=0.22 Preterm LBW 32.7% (352/1,078) 33.1% (211/638) 0.98 (0.80-1.21) p=0.87 0.94 (0.71-1.24) p=0.67 *Adjusted for reporting year, patient age, parity, infertility diagnosis, number of embryos transferred, number of prior ART cycles, prior miscarriage, reduction in fetal heart, multiple pregnancy, and implantation rate ** For adjusted analysis, preterm and very preterm delivery combined Kalra et al: OBGYN 2011

Summary In large database isolating on aspect of IVF Risk of Preterm labor minimal Risk of low birthweight apparent in: Term and preterm singletons Term and preterm twins Risk is Higher in the same women who conceives with both Risk is not apparent in women who use donor egg, where Preparation of the endometrium is the same in fresh and Transfer. Placentation an issue? What about other (modifiable) aspects of IVF? Extended Embryo Culture? Demographic Information of Patients with Live Birth Following Cleavage Stage versus Blastocyst Embryo Transfer (N=69,039) *Transferred on day 3 after oocyte retrieval Unpublished data ** Transferred on day 5/6 after oocyte retrieval

Preterm Delivery and Low Birthweight in Live Births Following Cleave Stage versus Blastocyst Embryo Transfer Unpublished data Association of Adverse Perinatal Outcome and Extended Embryo Culture Sub-Populations of Singleton Births in *Adjusted Odds Ratio: adjusted for reporting year, patient age, parity, infertility diagnosis, number of embryos transferred, number of prior ART cycles, prior miscarriage, reduction in fetal heart, multiple pregnancy, implantation rate. Blastocyst transfer RR for twins : RR 1.30 (1.26 2.35) If twins: PTD; RR 4.18 (4.10-4.28), p<0.001 LBW; RR 7.31 (7.10-7.53), p<0.001 Therefore Blast transfer increase morbidity in TWO ways Unpublished data California octuplets case dismays fertility experts Suleman said her fertility specialist told her about risks for the children. But she did not want to have only one or two embryos implanted. "Of course not, I wanted them all transferred.

Multiple Births U.S. National Birth Statistics 130,000 ASRM/SART Guidelines Twin Births 120,000 110,000 100,000 6000 4000 Tr iplet + Births 90,000 2000 1990 1995 2000 2005 Year CDC. National Vital Statistics Reports, 56(6), Dec 5, 2007 What do we know about children beyond the perinatal Period? Childhood Development Bowen, Lancet 1998 89 ICSI, 84 IVF and 80 conceived without medical assistance in a prospective cohort study in Australia 17% of ICSI children experienced developmental delay vs 2% and 1% in ivf & unassisted. Stromberg, Lancet, 2002 Swedish, Population based retrospective matched cohort of 5680 IVF conceived children and 11360 naturally conceived infants 2.0 (0.7-5.4) Systematic review in Human Repro update: 1) only 23 of 115 good quality, 2) Cannot conclude negative association, 3) Need to study greater number of older kids.

Altered behavior: Is there a link? One study noted prevalence of Autism spectrum disorder to be 3.4% (instead of 1.5%) (Bonduelle Hum Reprod. 2005 Feb; 20(2):413-9) Animal data? Mice derived from extended culture 1) alteration in anxiety (open quadrant maze, elevated zero maze) 2) impaired spatial memory (water maze, ability to find platform) This data was quoted in NY Times Ecker DJ, and, Schultz RM. Long-term effects of culture of preimplantation mouse embryos on behavior. Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1595-600. Maternal Report of Diagnoses and Interventions Maternal Report of: Unassisted IVF Relative Risk (95%CI) P value early intervention services 8.4% 12.6% 1.5 (0.7 3.4) 0.32 special education use 1.9% 6.8% 3.6 (0.8 17.1) 0.08 developmental delay 2.9% 4.2% 1.4 (0.3 6.2) 0.63 Unpublished data Molinaro et al., Parental Report of Childhood Behavioral Disorders is Not Different Among Offspring Conceived With and Without IVF Abnormal CBCL Scores Behavior Unassisted IVF p value OR (95% CI) Composite (any abnormal behavior) Behavioral Domains 10.2% 10.5% 0.9 1.03 (0.44, 2.44) Adjusted for delivery mode, 0.8 1.11 (0.43, 2.85) paternal age & education Anxiety 4.7 % 2.9 % 0.7 0.60 (0.15, 2.34) Somatic 3.7 % 3.8 % 1.0 1.02 (0.27, 3.83) Attention 0.9 % 1.9 % 0.6 2.06 (0.26, *) Aggressive 0.9 % 1.9 % 0.6 2.06 (0.26, *) Emotional 2.0 % 0.0 % 0.5 * Depressive 2.8 % 1.9 % 1.0 0.67 (0.00, 3.45) *=Unable to be calculated due to sparse data (outcomes) Unpublished data Molinaro et al., Parental Report of Childhood Behavioral Disorders is Not Different Among Offspring Conceived With and Without IVF

Preliminary Results Full Dataset Unadjusted Analysis Infertility diagnosis, drugs, or procedure Childhood Behavioral Diagnosis + TOTAL Risk (%) + 606 29,861 30,467 1.98 4,396 245,028 249,424 1.76 Relative Risk 1.13 (1.04, 1.23) 279,891 P=0.0066 Unpublished data Summary of What We Know Short term consequences of ART are apparent It is clear that there is increased morbidity for children conceived with IVF: We underestimate the complications that happen after we transfer care Less than 50% of those who conceive with IVF have a full term infant without any complications Disease process appears to be altered Low birth weight noted even when not premature The presentation and outcome of women with preclampsia is altered. Risk of congenital and chromosomal anomalies is associated with ICSI Summary of What We Do Not Know What are the clinical implications of the short term outcomes? Long term implications are unclear Do not know what about IVF confers risk Does ART result in abnormal placentation? OR Are factors associated abnormal implantation also associated with infertility (and need for IVF)? Why does FET reduce morbidity? How does extended culture increase morbidity?

Action Plan The subspecialty of REI needs to take the lead in addressing these issues Minimizing multiple pregnancy foremost goal Need to change the informed consent process Clear research priority Basic science link should be included What part of ART is associated with adverse outcome? Goal should be to identify modifiable treatment practices to reduce adverse outcome What We Cannot Do Underestimate the magnitude of this issue in the eyes of the public Blame it on the disease (or the patient) Let another discipline (or the government) dictate standard of care Use unproven technology without careful consideration and full disclosure Dismiss the risk to our patients Conclusion ART has allowed us to enter a Brave New World Practicing ART is a privilege, but also carries responsibility As scientists t and physicians i it is our responsibility to provide safe care The risks associated with ART are rare but cannot be minimized The evidence is still evolving, So lets. Not to throw the baby out with the bathwater